Reversine

TargetMol
Product Code: TAR-T1825
Supplier: TargetMol
CodeSizePrice
TAR-T1825-1mg1mg£96.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-2mg2mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-1mL1 mL * 10 mM (in DMSO)£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-5mg5mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-10mg10mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-25mg25mg£205.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-50mg50mg£259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1825-100mg100mg£402.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
CAS:
656820-32-5
Formula:
C21H27N7O
Molecular Weight:
393.495
Pathway:
GPCR/G Protein; Cell Cycle/Checkpoint; Neuroscience; Autophagy; Chromatin/Epigenetic
Purity:
0.9975
SMILES:
C1CCC(CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2[nH]cnc12
Target:
Aurora Kinase; Adenosine Receptor; Autophagy

References

1. Chen S, et al. J Am Chem Soc. 2004, 126(2), 410-411. 2. Perreira M, et al. J Med Chem. 2005, 48(15), 4910-4918. 3. D'Alise AM, et al. Mol Cancer Ther. 2008, 7(5), 1140-1149. 4. Qin HX, et al. Cytotechnology. 2013, 65(4), 643-653. 5. Lima K, Carlos J A E G, de Melo Alves-Paiva R, et al. Reversine exhibits antineoplastic activity in JAK2 V617F-positive myeloproliferative neoplasms[J]. Scientific reports. 2019, 9(1): 9895. 6. Carlos J A E G, Lima K, Coelho-Silva J L, et al. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia[J]. Cellular Oncology. 2020: 1-11.